Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation.
Inke
Area Industrial del Llobregat
C/Argent, 1
Castellbisbal, Barcelona 08755
Spain
+34 93 475 9600
www.inke.es
jsanchez@inke.es
